Woodline Partners LP - 31 Dec 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. Ordinary Shares, no par value per share (QNRX)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Quoin Pharmaceuticals, Ltd. Ordinary Shares, no par value per share
Symbol: QNRX
Shares outstanding: 29,319,684 shares
Disclosed Ownership: 2,785,370 shares
Ownership: 9.5%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 15:20:10 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	9.5%	2,785,370	2,785,370	0	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer